Remove Biotechnology Remove Licensing Remove Software
article thumbnail

Cyrus Biotech spins out company to expand reach of versatile drug development software

GeekWire

LinkedIn Photos) Seattle startup Cyrus Biotechnology is spinning out a business that will expand access to the company’s software technology, with the potential of supporting innovation in drug development, agriculture, synthetic biology and manufacturing.

Software 106
article thumbnail

Tech Moves: Seattle tech vet named CEO at Vouched; Sana hires chief scientific officer

GeekWire

(Vouched Photo) — Peter Horadan , a seasoned Seattle tech executive who was an executive at Avalara and later founded an accounting software startup called Lockstep, joined identity verification startup Vouched as its new CEO. Sana Photo) — Dhaval Patel joined Sana Biotechnology as executive vice president and chief scientific officer.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Nvidia accelerates enterprise adoption of generative AI

CIO Business Intelligence

“The AI solution stack varies according to how it will be used, which implies one must have intimate understanding of the AI use case — your AI workers and the end domain in which they work — and how to map the needs of the use case to the silicon, software, system hardware, and services.”

article thumbnail

Why the global chip shortage is making it so hard to buy a PS5

The Verge

And the way they’ll do it, these days, they’ll work on computers and they’ll design the chip using computer software, which will give you a file, which they can send to the manufacturer. I talk to a lot of software people. I talk to a lot of consumer product CEOs on the show.

Intel 134
article thumbnail

2021 Predictions: Why these tech, science and startup leaders are upbeat about the year ahead

GeekWire

And I’ll earn my A-class license on iRacing…. Software engineers will increasingly question the technology they are developing and the business models of the companies they are working for. I believe the events of 2020 have pushed innovation across many industries, including the biotechnology industry. The tech backlash is real.

Industry 145